Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 11Unknown 9Recruiting 6Terminated 2

Sponsor Class

OTHER 4OTHER_GOV 1INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 1774Neoplasms 1501Carcinoma, Non-Small-Cell Lung 1043Prostatic Neoplasms 957Colorectal Neoplasms 878Lung Neoplasms 800Pancreatic Neoplasms 572Carcinoma, Hepatocellular 542Leukemia, Myeloid, Acute 541Stomach Neoplasms 512Ovarian Neoplasms 507Neoplasm Metastasis 496Multiple Myeloma 495Recurrence 413Melanoma 386Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 355Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 305Endometrial Neoplasms 304Triple Negative Breast Neoplasms 299Glioblastoma 298Rectal Neoplasms 280Urinary Bladder Neoplasms 264Sarcoma 264Hematologic Neoplasms 264Colonic Neoplasms 254

Interventions

camrelizumab 1Tumor Burden 1Radiation 1Pyloromyotomy 1Botulinum Toxins, Type A 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Esophageal Diseases × Clear all
NCT02526095 2026-05-14

FREGAT

University Hospital, Lille

Recruiting
15,000 enrolled
Gastrointestinal

Esophageal Diseases

NCT00260585 2026-04-14

Esophageal Cancer Risk Registry

University of Pittsburgh

Recruiting
7,000 enrolled
Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Neoplasms, Gastroesophageal Reflux, Hernia, Hiatal

NCT04312633 2026-03-20

Clinical Utility of WATS3D: A 5-Year Prospective Study

CDx Diagnostics

Recruiting
90,000 enrolled
Gastrointestinal

Barrett Esophagus, Esophageal Diseases, Gastroesophageal Reflux

NCT06721520 2026-02-25

EMPTY

The Cleveland Clinic

Phase 2/3 Recruiting
170 enrolled
Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Motility Disorders, Gastroparesis

NCT05624099 2023-10-19

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Fujian Cancer Hospital

Phase 2 Recruiting
75 enrolled
Gastrointestinal

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

NCT05252078 2022-12-16

ALTER-E005

Jiangxi Provincial Cancer Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡